ArticleFrontiers in pharmacology2024

Adverse events in different administration routes of semaglutide: a pharmacovigilance study based on the FDA adverse event reporting system.

Kaibin Niu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.